Saving Roman: Biotechnology and the Fight Against Childhood Cancer
BIO Educates On Biologics
The National Journal named BIO as one of "Health Care's Top Players." The profile highlighted BIO's support for a pathway for biosimilars which protects patient safety and promotes continued innovation as well as the use of comparative effectiveness research to inform clinical decision-making. Read National Journal's article (.pdf format)
What's Happening With Animal Biotech?
Find out by tracking the blog posts of BIO's Barb Glenn as she blogs from the 7th Transgenic Animal Research Conference in Tahoe, California Check out the blog
Investor Perception Study Predicts Future of Biotech Sector
The BIO/Thomson Reuters Investor Perception Study is an in-depth assessment of Wall Street’s views of the biotech industry, its current challenges, its relative valuation, and the outlook for 2009. The analysis aims to provide BIO members with an insider’s perspective on what the investment community values in the current economic climate and help foster more effective communication between company management, shareholders, and potential investors. Download and read the report now (.pdf format)
